iRadimed
IRMD
104 hedge funds and large institutions have $241M invested in iRadimed in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 13 closing their positions.
109% more capital inflows, than outflows
Capital inflows: $33.1M | Capital outflows: $15.8M
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
15% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 33
7% more funds holding
Funds holding: 97 → 104 (+7)
2.26% more ownership
Funds ownership: 40.51% → 42.78% (+2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.99M |
| 2 |
RK Capital Management (Colorado)
Denver,
Colorado
|
+$3.13M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.51M |
| 4 |
G2 Investment Partners Management
New York
|
+$2.34M |
| 5 |
EAM Global Investors
Solana Beach,
California
|
+$1.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mondrian Investment Partners
London,
United Kingdom
|
-$3.89M |
| 2 |
Rice Hall James & Associates
San Diego,
California
|
-$2.26M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.35M |
| 4 |
Renaissance Technologies
New York
|
-$925K |
| 5 |
Soleus Capital Management
Greenwich,
Connecticut
|
-$924K |
IRMD Hedge Fund Activity: Q1 2022 in Review
104 of the 6,364 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q1 2022, worth a combined $241M — up 4.4% from $231M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new IRMD positions and 13 closed out — a net gain of 7 holders — while 38 added to existing stakes and 33 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $3.99M. The largest seller was Mondrian Investment Partners, exiting entirely with an estimated $3.89M sold.
- 104 institutional investors held iRadimed (IRMD) as of Q1 2022, up from 97 in Q4 2021.
- Funds reported $241M of iRadimed stock for Q1 2022, up 4.4% quarter-over-quarter.
- 20 funds opened new iRadimed positions in Q1 2022 and 13 closed out, a net change of +7 holders.
- The largest iRadimed buyer in Q1 2022 was Acadian Asset Management, an estimated $3.99M added.
- The largest iRadimed seller in Q1 2022 was Mondrian Investment Partners, an estimated $3.89M sold.
Based on aggregated 13F filings for Q1 2022.